secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2026-07-06T12:05:15+00:00
Accession:  0001295947-26-000029
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige closes LaCorium acquisition for ~$150M, prices $400M notes at 6.25% due 2034
--------------------------------------------------------------------------------

- Completed acquisition of LaCorium Health for ~$150M cash; LaCorium has ~$40M annual revenue, expected ~$12M EBITDA post-synergies.
- Priced $400M senior notes at 6.25% due 2034; proceeds to redeem existing 5.125% notes due 2028.
- Borrowed $95M additional term loans under existing credit agreement to finance part of acquisition.
- Q1 FY2027 earnings results to be released on August 6, 2026, with conference call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000029/0001295947-26-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000029/pbh-20260630.htm
  HTML page:      https://secwatch.observer/filing/0001295947-26-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer